Fellow Investor,
Many biotech companies have seen unfair drops in share price due to a broader market sell-off.
Novavax is down 67% YTD...
Moderna dropped 42.5% this year...
BioNTech lost 31% so far...
The biotech sector (XBI) as a whole is down about 40% YTD.
But while other investors are panicking, I'm looking at the opportunity.
There's a tiny biotech...trading at just $10 a share...
That's largely unknown to retail investors, but institutional investors are grabbing shares hand over fist.
Vanguard alone owns 12 million shares
BlackRock bought 6 million shares
J.P. Morgan bought 1.3 million shares
And it's not too late for you to get it in early too.
Everything you need to know about this revolutionary biotech can be found right here.
"The Buck Stops Here,"
Dylan Jovine
CEO & Founder,
Behind the Markets
P.S. Make sure to get in ASAP while the stock is still undervalued. It had previously reached a $90 high!
If you no longer wish to receive our emails, click the link below:
Unsubscribe
CLM LLC c/o DailyMarketAlerts 315 Ridgedale Avenue #556 East Hanover, New Jersey 07936 United States
No comments:
Post a Comment